Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

Dec 02, 2020
|
staff reporter

NEW YORK – Illumina said on Tuesday that China's National Medical Products Administration (NMPA) has approved the firm's NextSeq 550Dx instrument for genetic testing and diagnosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

To Keep Up

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

On the Rise in the City

The New York Times reports that a new viral variant of concern has been identified in New York City.

Nature Studies Present Single-Cell Map of Cell Cycle, Approach Identifies Cancer Treatment Resistance Pathways, More

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

  2. Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

  3. Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test

  4. Cue Health Nabs CE Mark for Molecular Point-of-Care COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.